MicroPort CRM Receives Approval in Japan for Alizea Bluetooth Pacemaker
PR94087
CLAMART, France, Jan. 17, 2022 /PRNewswire=KYODO JBN/ --
MicroPort CRM, a pioneering company in the field of Cardiac Rhythm Management,
headquartered in France, recently received PMDA Japanese regulation agency
approval for its latest range of implantable pacemakers, Alizea. The devices
are equipped with Bluetooth technology for streamlined remote monitoring when
paired with MicroPort CRM's SmartView Connect home monitor, already approved in
Japan.
Alizea pacemakers allow cardiologists to monitor devices remotely. The
SmartView Connect home monitor is designed to be placed at the patient's
bedside to allow for the regular transmission of detailed reports to the
cardiologist on the functioning of the pacing system, removing the need for
patients to visit the hospital for simple routine examinations, and thus
reducing the burden on the healthcare system. Alizea pacemakers and the
SmartView Connect home monitor work together to provide the cardiologist with
timely alerts and transmissions triggered by patients when they present
symptoms, leading to faster and more efficient patient care.
Noboru Shimizu, VP of MicroPort CRM Sales Japan, commented, "Around 64,000
patients are implanted with a pacemaker each year in Japan, and coupled with
the difficulties that have arisen from the current health crisis, there is a
growing need to monitor patients remotely, without them having to travel.
Thanks to Alizea pacemakers and its SmartView Connect monitor, we are
positioning ourselves in the Japanese market with the very best in cardiac
pacing. I am convinced that this will allow us to strengthen our presence in
Japan."
Benoît Clinchamps, President of MicroPort CRM, noted, "We successfully launched
Alizea in Europe in June 2021, and Japan is the second region to benefit from
its advanced technological functions. As part of our commitment to improve the
lives of as many patients as possible, and to support healthcare professionals
in their mission, we will continue to deploy Alizea and Smartview Connect
around the world."
About MicroPort CRM
MicroPort CRM is a pioneering company in the field of Cardiac Rhythm Management
(CRM), and a subsidiary of MicroPort Scientific Corporation (stock code:
00853.HK), with world headquarters in Clamart, near Paris, France. Through its
long-standing expertise in CRM, MicroPor CRM develops, manufactures and markets
cardiac pacemakers, implantable cardiac defibrillators, cardiac
resynchronization systems and ECG diagnostic solutions for the management of
cardiac rhythm disorders and heart failure, globally.
For more information, please refer to www.microport.com
SOURCE: MicroPort
Image Attachments Links:
Link: http://asianetnews.net/view-attachment?attach-id=412927
Caption: Alizea Bluetooth Pacemaker
Link: http://asianetnews.net/view-attachment?attach-id=412928
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。